Mª Eugenia Sáez Goñi has a degree in Pharmacy and a PhD in Molecular and Cell Biology from the University of Seville. During her training she received the prestigious Real Maestranza de Caballería and Ayuntamiento de Sevilla award. She has been a researcher at the Medical Genetics Unit of the Virgen del Rocio Hospital in Seville and later Head of the Cardiovascular Research Area at Neocodex, where she had the opportunity to lead national and international projects (Cenit , Fondo Tecnológico , FP7 , etc.). She has extensive experience in GWAS data analysis of both large case-control and longitudinal studies for the assessment of multifactorial diseases. She has authored more than 40 publications in international journals.
Antonio González Pérez holds a degree in Pharmacy from the University of Seville and studied a Masters in Epidemiology at the Harvard School of Public Health on a Fulbright scholarship. He was also a fellow in the division of Clinical Evaluation of the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS, Spanish Medicines Agency) and a epidemiologist at the company Neocodex. He has worked as a researcher at the Spanish Centre for Pharmacoepidemiologic Research (CEIFE) and was appointed as an expert for the AEMPS, where he has taught numerous courses in recent years. He has experience in the analysis of clinical databases such as GPRD, THIN and Saskatchewan for conducting pharmacoepidemiological studies and in the analysis and meta- analysis of GWAS in diseases such as Alzheimer's , Multiple Sclerosis or Parkinson's. He has authored over 50 publications in international journals.
Laura Madrid Márquez is a Software Engineer and has a MSc in Information and Communication Technology Management by the University of Seville. In the last years she has focused her professional career towards Health Informatics. She has experience in software development, data analysis and Machine Learning. She has previously worked for the Modernising Medical Microbiology group at Oxford University - Nuffield Department of Medicine, where she contributed to the development of a pipeline for DNA processing and various research projects on infectious diseases, as well as the design of APIs for combining clinical and genetic data in real time.